BridgeMD
New treatment option for Breath-holding Spell
Official title Breath-holding Spells and Its Management Study
ClinicalTrials.gov ID: NCT06628271
What this study is testing
- What it's testing
- The goal of this prospective population-based study is to evaluate the new disease description and management guidelines for breath-holding spells in children (Hellström Schmidt et al, Acta Paediatrica 2024) below the age of 5 years in southern Sweden. The main questions it aims to answer are: Does the disease description and management guidelines lead to the expected reduction in diagnostic interventions and are the clinical managements guidelines safe to use?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 0 to 60
You may be able to join if
- Below 5 years of age
- resident in Region Skåne (Sweden)
- suspected breath-holding spell
You likely can't join if
- previous investigation for breath-holding spell (previous spells are not a reason for exclusion)
The study team makes the final eligibility decision.
Where it's taking place
- Eslöv, Sweden
- Kristianstad, Sweden
- Lund, Sweden
- Malmö, Sweden
- Simrishamn, Sweden
- Sjöbo, Sweden
- Ystad, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0 months to 60 months. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Eslöv, Sweden; Kristianstad, Sweden; Lund, Sweden; Malmö, Sweden; Simrishamn, Sweden; Sjöbo, Sweden and 1 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.